3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
14
Lung Neoplasms
8
Prostatic Neoplasms
6
Colorectal Neoplasms
6
Neoplasms
5
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Smoking Cessation
2
Skin Carcinoma
2
Pain
2
Melanoma
2
Malignant Solid Neoplasm
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Smoking
1
Testicular Neoplasms
1
Spondylitis, Ankylosing
1
Smoking
1
Signs and Symptoms
1
Sepsis
1
Rectal Neoplasms
1
Psoriasis
1
Interventions
Specimen Handling
45
pembrolizumab
41
Biopsy
37
Magnetic Resonance Spectroscopy
35
Nivolumab
21
Paclitaxel
20
Gemcitabine
20
Radiosurgery
19
Carboplatin
19
Irinotecan
14
Ipilimumab
13
Cisplatin
12
Capecitabine
12
130-nm albumin-bound paclitaxel
12
Taxes
11
Pemetrexed
11
trastuzumab deruxtecan
10
olaparib
10
Leucovorin
10
Fluorouracil
10
Oxaliplatin
9
Fulvestrant
9
Cyclophosphamide
9
Cetuximab
9
durvalumab
8
abemaciclib
8
X-Rays
8
Drug Therapy
8
Bevacizumab
8
palbociclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Methods
×
90 days
×
Clear all
NCT04960787
2026-05-14
CREDIT
SWOG Cancer Research Network
Phase NA
Active not recruiting
331 enrolled